Diabetes type 2 management: what are the differences between DPP-4 inhibitors and how do you choose?
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1323878
Abstract: Type 2 diabetes mellitus (T2DM) is characterized by progressive beta cell dysfunction and insulin resistance. Pharmacotherapy to treat dysregulated glucose metabolism focuses on augmenting the insulin response to hyperglycemia, improving insulin sensitivity or altering glucose… read more here.
Keywords: differences dpp; management differences; type management; dpp inhibitors ... See more keywords